USFDA completes inspection at Dr Reddy’s with zero observations

BL Hyderabad Bureau Updated - June 17, 2023 at 11:07 AM.

The US Food & Drug Administration (USFDA) has completed a GMP inspection at Dr Reddy’s Laboratories’ API manufacturing facility (CTO-3) in Bollaram, Hyderabad.

The inspection was conducted from June 12, 2023, to June 16, 2023. The inspection closed with zero observations.

The formulations manufacturing facility in Srikakulam (FTO SEZ PU2) of the Hyderabad-based Dr Reddy’s has also received the Establishment Inspection Report (EIR) from the USFDA.

The Agency has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is “closed”, the company said.

Sign up for newsletters, unlock features and do more on The Hindu
LOG IN
Support our reporting.
SUBSCRIBE NOW
Published on June 17, 2023 05:37
Tags

This is a Premium article available exclusively to our subscribers.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
If you're already a subscriber
Access just this article

You have reached your free article limit.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
If you're already a subscriber
Access just this article

You have reached your free article limit.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
or read this article by Downloading TheHindu Businessline News app
If you're already a subscriber
Access just this article

TheHindu Businessline operates by its editorial values to provide you quality journalism.

Support our reporting.
Subscribe
This is your last free article.
to read unlimited content from TheHindu Businessline
Subscribe
Stay updated on Markets,Economy, Agri & more.
Get TheHindu Businessline News App on
Recommended Articles